
Please try another search
(Reuters) - Billionaire investor Carl Icahn is urging life sciences company Illumina Inc (NASDAQ:ILMN) to divest cancer test developer Grail Inc and said on Wednesday that his director candidates will be best placed to pursue this goal.
In his second letter to Illumina shareholders this week, Icahn wrote the "only path forward is for Grail to be divested".
Illumina said on Monday it will divest Grail, which it purchased in 2021, if it loses its appeal to the European Commission where regulators said last year they intend to require Illumina to unwind the $7.1 billion takeover.
The company did not have an immediate comment on Icahn's latest letter.
Icahn, who owns 1.4% of Illumina, launched a proxy fight earlier this week and is seeking three board seats at the company after weeks of private discussions with Illumina sputtered.
"We don't believe that it is possible for Illumina shareholders to receive the full value of GRAIL if Illumina pursues both the appeals process and the divestment process at the same time," Icahn wrote.
Illumina won its case against the U.S. Federal Trade Commission which had tried to argue the deal should not go ahead for antitrust reasons.
Icahn's push at Illumina could become the year's most high-profile proxy contest after Nelson Peltz ended his quest for a seat at Disney and Daniel Loeb reached an agreement with Bath & Body Works. A handful of activist investors are still pressuring Salesforce (NYSE:CRM) to make changes.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.